IE56400B1 - Novel 6alpha-methylprednisolone derivatives and their manufacture and use - Google Patents
Novel 6alpha-methylprednisolone derivatives and their manufacture and useInfo
- Publication number
- IE56400B1 IE56400B1 IE2944/83A IE294483A IE56400B1 IE 56400 B1 IE56400 B1 IE 56400B1 IE 2944/83 A IE2944/83 A IE 2944/83A IE 294483 A IE294483 A IE 294483A IE 56400 B1 IE56400 B1 IE 56400B1
- Authority
- IE
- Ireland
- Prior art keywords
- preparation
- compound
- group
- fora
- butyryl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical class C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 9
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000013543 active substance Substances 0.000 claims description 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 7
- -1 Isobutyryl Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000003470 adrenal cortex hormone Substances 0.000 claims description 3
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims 2
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 1
- 239000011505 plaster Substances 0.000 claims 1
- 150000003116 prednisolone derivatives Chemical class 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 abstract description 3
- 208000010668 atopic eczema Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 230000000241 respiratory effect Effects 0.000 abstract description 2
- 208000017520 skin disease Diseases 0.000 abstract description 2
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012043 crude product Substances 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 125000001246 bromo group Chemical group Br* 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- CPUKWYXYHPOQJH-RDQPJNLGSA-N (8r,9s,10s,13s,14s)-17-ethenyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)(C(=CC4)C=C)[C@@H]4[C@@H]3CCC21 CPUKWYXYHPOQJH-RDQPJNLGSA-N 0.000 description 1
- JAFMOTJMRSZOJE-UHFFFAOYSA-N 1,1,1-trimethoxybutane Chemical compound CCCC(OC)(OC)OC JAFMOTJMRSZOJE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 241000575946 Ione Species 0.000 description 1
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical class O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- BQFPCTXLBRVFJL-UHFFFAOYSA-N triethoxymethylbenzene Chemical compound CCOC(OCC)(OCC)C1=CC=CC=C1 BQFPCTXLBRVFJL-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823248435 DE3248435A1 (de) | 1982-12-23 | 1982-12-23 | Neue 6(alpha)-methylprednisolon-derivate ihre herstellung und verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE832944L IE832944L (en) | 1984-06-23 |
| IE56400B1 true IE56400B1 (en) | 1991-07-17 |
Family
ID=6182025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2944/83A IE56400B1 (en) | 1982-12-23 | 1983-12-14 | Novel 6alpha-methylprednisolone derivatives and their manufacture and use |
Country Status (21)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19644679C2 (de) * | 1996-10-28 | 1999-06-02 | Freudenberg Carl Fa | Wischbezug |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1026160A (en) * | 1964-04-29 | 1966-04-14 | American Cyanamid Co | Pregnatrienes |
| DE2645104C2 (de) * | 1976-10-04 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung |
-
1982
- 1982-12-23 DE DE19823248435 patent/DE3248435A1/de not_active Withdrawn
-
1983
- 1983-11-03 DE DE8383110948T patent/DE3372970D1/de not_active Expired
- 1983-11-03 EP EP83110948A patent/EP0112467B1/de not_active Expired
- 1983-11-03 AT AT83110948T patent/ATE28878T1/de active
- 1983-11-16 CA CA000441287A patent/CA1250571A/en not_active Expired
- 1983-12-08 AU AU22202/83A patent/AU2220283A/en not_active Abandoned
- 1983-12-14 IE IE2944/83A patent/IE56400B1/en not_active IP Right Cessation
- 1983-12-15 IL IL70452A patent/IL70452A/xx not_active IP Right Cessation
- 1983-12-16 SU SU833673977A patent/SU1299514A3/ru active
- 1983-12-19 GB GB08333741A patent/GB2132620B/en not_active Expired
- 1983-12-20 RO RO83112962A patent/RO88666A/ro unknown
- 1983-12-20 DD DD83258236A patent/DD210694A5/de unknown
- 1983-12-21 GR GR73318A patent/GR79453B/el unknown
- 1983-12-21 PL PL1983245246A patent/PL141513B1/pl unknown
- 1983-12-21 HU HU834382A patent/HU187939B/hu not_active IP Right Cessation
- 1983-12-22 NO NO834759A patent/NO156410C/no unknown
- 1983-12-22 ZA ZA839573A patent/ZA839573B/xx unknown
- 1983-12-22 ES ES528323A patent/ES8502128A1/es not_active Expired
- 1983-12-22 PT PT77880A patent/PT77880B/pt unknown
- 1983-12-23 CS CS839879A patent/CS236900B2/cs unknown
- 1983-12-23 DK DK597783A patent/DK159118C/da not_active IP Right Cessation
- 1983-12-23 JP JP58242345A patent/JPS59130300A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1251783A (en) | 6.alpha.-METHYLPREDNISOLONE DERIVATIVES AND THEIR MANUFACTURE AND USE | |
| GB1599863A (en) | Pharmaceutical compositions for use in the inhibition of the biosynthesis of mevalonic acid | |
| US3318926A (en) | 7alpha-methyl-16alpha-hydroxy-estrones | |
| CA1303607C (en) | 6.alpha.-METHYLCORTICOIDS AND THEIR MANUFACTURE AND USE | |
| GB2124230A (en) | 616-dimethyl corticoids, their preparation and use | |
| HU182049B (en) | Process for producing d-homo-steroides | |
| JPS5931800A (ja) | １９−チオ−アンドロスタン誘導体 | |
| US4912098A (en) | Antiinflammatory 6 alpha-methylhydrocortisones | |
| US4473564A (en) | 19-Thio-androstane derivatives | |
| JPH033679B2 (enrdf_load_stackoverflow) | ||
| IE56400B1 (en) | Novel 6alpha-methylprednisolone derivatives and their manufacture and use | |
| PL111825B1 (en) | Process for preparing novel corticoids | |
| US4619922A (en) | 6α, 16α-dimethyl corticoids | |
| GB2105724A (en) | Corticoid 17-ester 21-thioesters | |
| Holness et al. | The identification of some adrenocortical steroids in urine | |
| US3753979A (en) | Substituted 1,2alpha-methylene-6,7alpha-halomethylene-20-spirox-4-en-3-ones or 3-ols and acyl esters thereof | |
| JPS63280094A (ja) | ３−メチレン−４−アンドロステン−１７−オン、その製造法、および該化合物を含有する、エストロゲン生合成阻止作用および受胎能変更作用を有する医薬 | |
| US3824260A (en) | Novel pregnanoic acid derivatives | |
| Elks et al. | 835. Studies in the synthesis of cortisone. Part XV. Improvements in the conversion of hecogenin into 3β: 12β-diacetoxy-5α: 25 D-spirostan-11-one and a study of the isomeric 11: 12-ketols | |
| CA1146534A (en) | Hydrocortisone esters, pharmaceutical formulations containing these and processes for their preparation | |
| Ellis et al. | 848. Some 5α: 6α-epoxy-3-oxo-steroids | |
| IE45305B1 (en) | New corticoids | |
| FI65263B (fi) | Foerfarande foer framstaellning av nya som progestativa och/eller ovulationshindrande medel anvaendbara 4,9-pregnadien-3,20-dionderivat | |
| JPS60139697A (ja) | ヒドロコーチゾン誘導体、その製法及びコルチコイド製剤 | |
| JPS5817480B2 (ja) | コルチコステロイド ２１− エステルユウドウタイノ セイゾウホウ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |